ICD-10-CM Billable Code

H35.713

Central serous chorioretinopathy, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Central serous chorioretinopathy (CSC) is a condition affecting the retina, the light-sensitive tissue at the back of the eye. When it occurs in both eyes simultaneously, it is referred to as bilateral CSC, coded as H35.713 in the ICD-10 classification. This condition can lead to visual disturbances, but most cases tend to resolve over time with appropriate management.

Causes & Symptoms

Clinical Causes: Stress and hormonal imbalances: Elevated cortisol levels are often linked to CSC. Use of corticosteroid medications: Both systemic and local steroids can contribute. Sleep disturbances: Stress-related sleep issues may be a factor. Age and gender: Middle-aged men are more commonly affected. Type A personality traits and high-stress lifestyles: Such factors have been associated with increased risk. Other medical conditions: Some associations include hypertension and gastrointestinal conditions.

Key Symptoms: Blurred or distorted vision in one or both eyes Seeing dark or gray spots (scotomas) A sense of shadow or curtain across the vision Colors appearing faded or less vibrant Sudden visual changes that may improve spontaneously over weeks to months

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive eye examination, including visual acuity tests and detailed imaging. Key diagnostic tools include:

Treatment Protocols: Many cases of bilateral CSC resolve on their own without treatment. When intervention is needed, options include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H35.713 a billable ICD-10 code?
Yes, H35.713 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H35.713?
Clinical documentation must specify the nature of Central serous chorioretinopathy, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference